Comment by
Oilminerdeluxe on Mar 22, 2024 3:59pm
Ungodly frustrating. But what can you do? Hope we get a nice update whenever it arrives.
Comment by
Eoganacht on Mar 22, 2024 4:10pm
I think this is good. The trial still ends at 450 days past initial response, but Theralase will continue to compile durable response data. I don't think any prospective treatment we've heard about so far will be able to compete with Ruvidar PDT's durable response and Theralase will have the data to prove it.
Comment by
Oilminerdeluxe on Mar 22, 2024 4:26pm
Hope you are right. We deserve a boost or two upwards. Hopefully, Roger's well of funds will not dry out going forward when the next need arises..
Comment by
Eoganacht on Mar 22, 2024 4:36pm
I'm hoping that Theralase has already made a deal but that it's dependent on getting BTD. As of 4 days ago (March 18 Corporate Presentation) Theralase was still projecting BTD in the first half of 2024.
Comment by
Oilminerdeluxe on Mar 22, 2024 4:54pm
Good. I didn't even know a new presentation was out, lol. That sounds within our grasp. Fingers crossed.
Comment by
DJDawg on Mar 22, 2024 5:47pm
any changes on the March 18 slide deck vs the previous one?
Comment by
Alamir1111 on Mar 22, 2024 6:32pm
Oct 23 presentation shows Resarch capital as analyst March 18 no mention of them
Comment by
Alamir1111 on Mar 22, 2024 7:15pm
Premarket. Study device .projected mid 2023 end 2025 https://www.fda.gov/medical-devices/classify-your-medical-device/how-determine-if-your-product-medical-device#:~:text=Medical%20devices%20range%20from%20simple,kits%2C%20and%20blood%20glucose%20meters.
Comment by
Mikee3003 on Mar 22, 2024 7:15pm
Eoganacht - I very much doubt a deal is in place dependent on getting BTD. If this was the case TLT would be handcufed with a LOI and I would certainly expect that a if there was a signed LOI it would be considered material information and a news release would need to be issued.
Comment by
Eoganacht on Mar 23, 2024 11:48am
Mikee3003 - as a secret agent for Theralase management, don't you think I'd know better than you? But maybe I'm just another poor schnook long who can't resist speculating about his Hail Mary pass retirement funding longshot. Eh?
Comment by
DeathXray33 on Mar 23, 2024 12:35pm
"I'm just another poor schnook long who can't resist speculating about his Hail Mary pass retirement funding longshot." Lol... I'm right next to you. We'll be able to go camping, hiking & fishing a lot more. Roger & Sherri are awesome!!!
Comment by
menoalittle on Mar 23, 2024 12:43pm
>> But maybe I'm just another poor schnook long who can't resist speculating about his Hail Mary pass retirement funding longshot. Hey, I'm right there with you, eoganacht ! (for 5 years or so now... and it's getting mighty long in the tooth.) but, what do I know...
Comment by
Eoganacht on Mar 22, 2024 4:31pm
Once Ruvidar PDT is approved Theralase will be able to point to it's superior efficacy immediately and it's superior durable response will emerge more and more over time as Ruvidar maintains it's CR rate while Adstliladrin (for example) declines. With safety and only one or two treatments required Ruvidar will become the obvious choice.
Comment by
Mikee3003 on Mar 22, 2024 7:42pm
JohnandRose22 - Perhaps our friend Eoganacht is the "unofficial" communications person for Theralase??? Call me paranoid, suspicious.........are there any communications with Theralase's executive members or any employees?........hmmmmmmmmm
Comment by
Johnandrose22 on Mar 22, 2024 7:56pm
Ah, Mikee3003, thank you....After over 10 years investing in this company and attending this forum there is little that can surprise me. My dilemma is this.....At this point, I trust the integrity, honesty, guidance of Eoganacht and others on this board more than I do the company's CEO and his administration. I don't think I'm alone with this. That's a problem.
Comment by
Eoganacht on Mar 22, 2024 4:03pm
Theralase is now following up with patients for 60 months - exactly the same time period as Ferring is using with Adstiladrin treatments. This will facilitate a durable reponse comparison of the two treatments.
Comment by
riverrrow on Mar 23, 2024 4:11pm
I'm sure everybody here would agree that AA would be huge. The sooner the better. Thanks for your post.
Comment by
Longholder99 on Mar 23, 2024 6:07pm
Does it make sense that if AA is in the crosshairs. Enrollment has stalled because after AA is acheived they can start charging money for treatments. Saving the bank account Would explain trial parameter changes as well. Just a thought.
Comment by
StevenBirch on Mar 23, 2024 8:05pm
Would also explain why Roger is doing the small PPs every couple of months, I doubt they can keep going back to the same people if there was going to be a major delay. They must have some idea they are close and we just have to suffer these little price corrections until it all happens.
Comment by
riverrrow on Mar 23, 2024 10:21pm
While the number of patients that have reached 450 days is much smaller than the goal of 100 patients and therefore the confidence level in the CR% is smaller than desired, surely the lack of side effects and especially lack of serious side effects is a huge plus that should warrant huge consideration at this stage of the trial. BTD an AA here we come.
Comment by
Galaxym31 on Mar 24, 2024 12:22pm
Powers that be should stop torturing cancer victims with multiple treaments and severe side effects eh .